Montis Biosciences
Montis Biosciences • Beyond complement
Leuven, Belgium · $9.1M raised
- Headquarters
- Leuven
- Business Model
- B2B
- Website
- montisbio.com
- Total Funding
- $9.1M
- Last Round
- $9.1M SeedFeb 2025
- Rounds
- 1
About
Montis Biosciences develops cutting-edge C1q-targeting antibody therapies for neuroinflammatory diseases and cancer.
Summary
Montis Biosciences is a Biotech company based in Leuven, Belgium. It has raised $9.1M in total across 1 round, most recently a $9.1M Seed round in Feb 2025. Investors include Polaris Partners, 3E Bioventures Capital and Takeda (JP).
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company